Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor α in pregnant rats

Hypertension

Volumn 52, Issue 6, 2008, Pages 1168-1172

  LaMarca, Babbette ^a   Wallukat, Gerd ^b   Llinas, Mayte ^a   Herse, Florian ^b   Dechend, Ralf ^b   Granger, Joey P ^a,c  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

AT1 receptor activation; Autoantibodies; Hypertension; Inflammatory cytokines; Pregnancy

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; AUTOANTIBODY; LOSARTAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CIRCULATION; CONTROLLED STUDY; FEMALE; ISCHEMIA; MATERNAL HYPERTENSION; NONHUMAN; ORGAN PERFUSION; PERFUSION PRESSURE; PLACENTA DISORDER; PREGNANCY; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STIMULATION; UTERUS;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AUTOANTIBODIES; BLOOD PRESSURE; FEMALE; HYPERTENSION, PREGNANCY-INDUCED; ISCHEMIA; LOSARTAN; PLACENTA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; TUMOR NECROSIS FACTOR-ALPHA; UTERUS;

EID: 57449102345     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.120576     Document Type: Article

References (21)

1. Saftlas AF, Olson DR, Franks AL, Alrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States. Am J Obste Gynecol. 1990;163:460-465.
2. August P, Lindheimer MD. Pathophysiology of preeclampsia. Hypertension. 1995;142:2407-2426.
3. Chesley LC. Hypertensive Disorders in Pregnancy. New York, NY: Appleton-Century-Crofts; 1978:777-822.
4. Roberts JM, Lain KY. Recent insights into the pathogenesis of preeclampsia. Placenta. 2002;23:359-372.
5. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol. 1998;16:5-15.
6. Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension. 2005;46: 1077-1085.
7. Granger JP, Alexander BT, Bennett WA, Khalil RA. Pathophysiology of pregnancy-induced hypertension. Microcirculation. 2002;9:147-160.
8. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek MH, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2007;10:1113-1152.
9. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103:945-952.
10. Xia Y, Wen H, Bobst S, Day MC, Kellems RE. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Invest. 2003;10:82-93.
11. Dechend R, Viedt C, Muller DN, Ugele B, Brandes RP, Wallukat G, Park JK, Janke J, Barta P, Theuer J, Fiebeler A, Homuth V, Dietz R, Haller H, Kreuzer J, Luft FC. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation. 2003;107:1632-1639.
12. Thway TM, Shlykov SG, Day MC, Sanborn BM, Gilstrap LC III, Xia Y, Kellems RE. Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization mrough angiotensin receptor activation. Circulation. 2004;110:1612-1619.
13. Walther T, Wallukat G, Jank A, Battel S, Schultheiss HP, Faber R, Stepan H. Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension. 2005;46: 1275-1279.
14. Bobst SM, Day MC, Gilstrap LC, Xia Y, Kellems RE. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypertens. 2005;18:330-336.
15. Dechend R, Homum V, Wallukat G, Müller DN, Krause M, Dudenhausen J, Haller H, Luft FC. Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J Soc Gynecol Investig. 2006;13:79-86.
16. Dechend R, Müller DN, Wallukat G, Homuth V, Krause M, Dudenhausen J, Luft FC. Activating auto-antibodies against the AT1 receptor in preeclampsia. Autoimmun Rev. 2005;4:61-65.
17. Xia Y, Ramin SM, Kellems RE. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension. 2007;50:269-275.
18. Granger JP, LaMarca BB, Cockrell K, Sedeek M, Balzi C, Chandler D, Bennett W. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med. 2006;122:383-392.
19. LaMarca BB, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension. 2005;46: 1022-1025.
20. Dechend R, Gratze P, Wallukat G, Shagdarsuren E, Plehm R, Brasen JH, Fiebeler A, Schneider W, Caluwaerts S, Vercruysse L, Pijnenborg R, Luft FC, Muller DN. Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension. 2005;45:742-746.
21. Alexander BT, Cockrell K, Cline FD, Llinas MT, Sedeek M, Granger JP. Effect of angiotensin II synthesis blockade on the hypertensive response to chronic reductions in uterine perfusion pressure in pregnant rats. Hypertension. 2001;38:742-745.